Clinical Trial Update: " SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"

View source ↗

Summary

This clinical trial update reports on the SAVE Study evaluating switching fast-metabolizer kidney transplant recipients from Advagraf to Envarsus tacrolimus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Failure

Drugs mentioned

• Advagraf (tacrolimus)
• Envarsus (tacrolimus)

Snippet

Sponsor: Nantes University Hospital | Conditions: Renal Transplant Failure | Status: ACTIVE_NOT_RECRUITING